> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Drugs for Cytomegalovirus in Transplantation
- URL: https://www.fdaweb.com/draft-guide-on-drugs-for-cytomegalovirus-in-transplantation-2/
- Published: 2018-05-21T12:00:00.000Z
- Updated: 2026-09-15T00:06:20.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141491

*Federal Register* notice: FDA has published a draft guidance on “Cytomegalovirus in Transplantation: Developing Drugs to Treat or Prevent Disease.” The document provides recommendations for developing such drugs for treating patients who have undergone solid organ or hematopoietic stem cell transplantation. It addresses FDA’s current thinking on the overall development program and clinical trial designs for drugs and biologics to support an indication for treating/preventing cytomegalovirus disease. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-05-21/pdf/2018-10733.pdf?ref=fdaweb.com).